JANX logo

Janux Therapeutics (JANX) Working capital

annual working capital:

$1.02B+$680.00M(+202.26%)
December 31, 2024

Summary

  • As of today (June 17, 2025), JANX annual working capital is $1.02 billion, with the most recent change of +$680.00 million (+202.26%) on December 31, 2024.
  • During the last 3 years, JANX annual working capital has risen by +$651.99 million (+179.01%).
  • JANX annual working capital is now at all-time high.

Performance

JANX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

quarterly working capital:

$1.01B-$10.37M(-1.02%)
March 31, 2025

Summary

  • As of today (June 17, 2025), JANX quarterly working capital is $1.01 billion, with the most recent change of -$10.37 million (-1.02%) on March 31, 2025.
  • Over the past year, JANX quarterly working capital has increased by +$357.78 million (+55.21%).
  • JANX quarterly working capital is now -1.02% below its all-time high of $1.02 billion, reached on December 31, 2024.

Performance

JANX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

JANX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+202.3%+55.2%
3 y3 years+179.0%+185.6%
5 y5 years+10000.0%-

JANX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+221.7%-1.0%+245.2%
5 y5-yearat high>+9999.0%-1.0%+7708.7%
alltimeall timeat high>+9999.0%-1.0%+7708.7%

JANX Working capital History

DateAnnualQuarterly
Mar 2025
-
$1.01B(-1.0%)
Dec 2024
$1.02B(+202.3%)
$1.02B(+56.5%)
Sep 2024
-
$649.15M(-0.2%)
Jun 2024
-
$650.39M(+0.4%)
Mar 2024
-
$648.06M(+92.8%)
Dec 2023
$336.21M(+6.4%)
$336.21M(-1.3%)
Sep 2023
-
$340.72M(+16.9%)
Jun 2023
-
$291.40M(-4.5%)
Mar 2023
-
$305.29M(-3.4%)
DateAnnualQuarterly
Dec 2022
$315.93M(-13.3%)
$315.93M(-3.7%)
Sep 2022
-
$328.00M(-4.9%)
Jun 2022
-
$345.07M(-2.0%)
Mar 2022
-
$352.14M(-3.3%)
Dec 2021
$364.22M(+2727.6%)
$364.22M(-3.4%)
Sep 2021
-
$377.12M(-2.7%)
Jun 2021
-
$387.40M(+500.5%)
Mar 2021
-
$64.51M(+400.8%)
Dec 2020
$12.88M(-424.5%)
$12.88M
Dec 2019
-$3.97M
-

FAQ

  • What is Janux Therapeutics annual working capital?
  • What is the all time high annual working capital for Janux Therapeutics?
  • What is Janux Therapeutics annual working capital year-on-year change?
  • What is Janux Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Janux Therapeutics?
  • What is Janux Therapeutics quarterly working capital year-on-year change?

What is Janux Therapeutics annual working capital?

The current annual working capital of JANX is $1.02B

What is the all time high annual working capital for Janux Therapeutics?

Janux Therapeutics all-time high annual working capital is $1.02B

What is Janux Therapeutics annual working capital year-on-year change?

Over the past year, JANX annual working capital has changed by +$680.00M (+202.26%)

What is Janux Therapeutics quarterly working capital?

The current quarterly working capital of JANX is $1.01B

What is the all time high quarterly working capital for Janux Therapeutics?

Janux Therapeutics all-time high quarterly working capital is $1.02B

What is Janux Therapeutics quarterly working capital year-on-year change?

Over the past year, JANX quarterly working capital has changed by +$357.78M (+55.21%)
On this page